Chemotherapy for Bladder Cancer

Chemotherapy (also called chemo) uses drugs to destroy or damage fast-growing cells like cancer cells. In bladder cancer, chemotherapy may be given before surgery to shrink the tumor in the bladder or kill microscopic cells that no scan or blood test shows, but that may be in your bloodstream, lymph nodes or organs. This is called neoadjuvant chemotherapy. It can also be used after surgery to kill any remaining cancer cells, or as the main treatment if surgery or radiation isn’t an option. Chemo drugs are given in different ways. This includes intravenously (IV into a vein), orally by a pill, or by injection. Chemotherapy can be given directly into the bladder (intravesical therapy) for bladder cancer that has not invaded the muscle of the bladder (non-muscle invasive bladder cancer).

These are the chemotherapy drugs that are used most often to treat bladder cancer. New treatments become available all the time, so this may not be a complete list.

Please note: The side effects listed here do not represent a comprehensive list. It's important to discuss all potential side effects of a drug with your healthcare team. Be sure to tell your healthcare team about any side effects you do have.

Expand

All Available Treatments

IV (through a vein) =      Pill =

Treatment Type

Platinum-based chemotherapy (MIBC)

Drug Names
Platinol® (Cisplatin) (IV)
Paraplatin® (Carboplatin) (IV)
Important Things to Know
  • Bladder Cancer Type: Muscle-Invasive Bladder Cancer
  • Cisplatin is considered the standard for bladder cancer but may not be safe for everyone due to kidney function or other health issues. Carboplatin may be used as an alternative. Kidney function should be monitored closely during treatment.
  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding. 

Treatment Type

Antimetabolite

Drug Names
Gemzar® (Gemcitabine) (IV)
MIBC and NMIBC intravesical (IV)
Important Things to Know
  • Bladder Cancer Type: Muscle-Invasive and Non-Muscle Invasive  
  • Often combined with cisplatin for neoadjuvant treatment of bladder cancer or as first or second-linetreatment of advanced or metastatic bladder cancer. May be used on its own in patients who can't tolerate combination therapy.
  • Low blood counts are a potential side effect that may put you at risk for anemia, infection, or bleeding.

Treatment Type

Intravenous infusion (IV)

Drug Name
Inlexzo (Gemcitabine) (NMIBC)
Potential Side Effects
Urinary, kidney, or bladder changes
Important Things to Know
  • Placed using a catheter & then removed in 3 weeks

Treatment Type

Combination chemotherapy (MVAC)

Drug Name
MVAC – Methotrexate, Vinblastine, Doxorubicin (Adriamycin®) and Cisplatin (IV)
Important Things to Know
  • Bladder Cancer Type: Muscle-Invasive
  • MVAC is a combination regimen used for neoadjuvant treatment before surgery and for advanced/metastatic bladder cancer.
  • Often used in patients who are healthy enough to tolerate aggressive therapy.
  • Requires close monitoring due to potential for serious side effects.

Treatment Type

Intravesical therapy

Drug Name
Mutamycin® (Mitomycin C) (NMIBC)
Important Things to Know
  • Bladder Cancer Type: Non-Muscle Invasive  
  • Delivered directly into the bladder via catheter.  
  • Used for early-stage (non-muscle invasive) bladder cancer after tumor resection.  
  • Avoid urination too soon after administration to allow the drug to work.

Treatment Type

Direct instillation into the bladder

Drug Name
Zusduri (itomycin) (NMIBC)
Important Things to Know
  • A drug approved in June for a chemo installation that is a sustained-release gel rather than a liquid.
  • It is not a system that needs removal at the end of a cycle.